부산대학교 도서관

Mensali N; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Köksal H; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Joaquina S; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Wernhoff P; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Casey NP; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Romecin P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029), Madrid, Spain.; Panisello C; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029), Madrid, Spain.; Rodriguez R; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBER-ONC), Instituto de Salud Carlos III, Madrid, Spain.; Vimeux L; Université de Paris, Institut Cochin, INSERM, CNRS, Equipe labellisée Ligue Contre le Cancer, F-75014, PARIS, France.; Juzeniene A; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Myhre MR; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Fåne A; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Ramírez CC; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital, CSIC, University of Sevilla, CIBER-ONC, 41013, Seville, Spain.; Maggadottir SM; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Duru AD; NSU Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.; Georgoudaki AM; NSU Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Grad I; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Maturana AD; Laboratory of Animal Cell Physiology, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.; Gaudernack G; Department of Cancer Immunology, Oslo University Hospital, Oslo, Norway.; Kvalheim G; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Carcaboso AM; SJD Pediatric Cancer Center Barcelona, Institut de Recerca Sant Joan de Deu, Barcelona, 08950, Spain.; de Alava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital, CSIC, University of Sevilla, CIBER-ONC, 41013, Seville, Spain.; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, 41009, Seville, Spain.; Donnadieu E; Université de Paris, Institut Cochin, INSERM, CNRS, Equipe labellisée Ligue Contre le Cancer, F-75014, PARIS, France.; Bruland ØS; Department of Oncology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Menendez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029), Madrid, Spain.; CIBER-ONC, ISCIII, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Inderberg EM; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway. elsin@rr-research.no.; Wälchli S; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway. sebastw@rr-research.no.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Kok N; Glycostem Therapeutics B.V., Oss, the Netherlands.; Ozkazanc D; Glycostem Therapeutics B.V., Oss, the Netherlands.; van Vliet AA; Glycostem Therapeutics B.V., Oss, the Netherlands.; Steenmans D; Glycostem Therapeutics B.V., Oss, the Netherlands.; Singh SP; Pamgene International B.V., 's-Hertogenbosch, the Netherlands.; Sutlu T; Acibadem University, Istanbul, Turkiye.; Georgoudaki AM; Glycostem Therapeutics B.V., Oss, the Netherlands.; Raimo M; Glycostem Therapeutics B.V., Oss, the Netherlands.; Spanholtz J; Glycostem Therapeutics B.V., Oss, the Netherlands.; Duru AD; Glycostem Therapeutics B.V., Oss, the Netherlands.

Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Rea A; University Pompeu Fabra (UPF), Barcelona, Spain.; Santana-Hernández S; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Institut de Biotecnologia i Biomedicina, Cell Biology, Physiology and Immunology Deptartments, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Villanueva J; University Pompeu Fabra (UPF), Barcelona, Spain.; Institut de Biotecnologia i Biomedicina, Cell Biology, Physiology and Immunology Deptartments, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Sanvicente-García M; University Pompeu Fabra (UPF), Barcelona, Spain.; Cabo M; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Suarez-Olmos J; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Quimis F; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Qin M; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Llorens E; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Blasco-Benito S; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Torralba-Raga L; Precision Immunotherapy Alliance, The University of Oslo, Oslo, Norway.; Department of Cancer Immunology, Institute for Cancer Research Oslo, Oslo University Hospital, Oslo, Norway.; Perez L; Department of Immunology, Hospital Clínic de Barcelona (HCB), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Joint Platform of Immunotherapy Hospital Sant Joan de Deu - HCB, University of Barcelona, Barcelona, Spain.; Bhattarai B; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.; Alari-Pahissa E; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Georgoudaki AM; Glycostem Therapeutics, Oss, the Netherlands.; Balaguer F; Department of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Barcelona, Spain.; Juan M; Department of Immunology, Hospital Clínic de Barcelona (HCB), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Joint Platform of Immunotherapy Hospital Sant Joan de Deu - HCB, University of Barcelona, Barcelona, Spain.; Pardo J; IIS Aragon Foundation/ Dpt. Microbiology, Radiology Pediatry and Public Health, University of Zaragoza, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERinfec), Zaragoza, Spain.; Celià-Terrassa T; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Rovira A; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology, Hospital del Mar, Barcelona, Spain.; Möker N; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.; Zhang C; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.; Colonna M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.; Spanholtz J; Glycostem Therapeutics, Oss, the Netherlands.; Malmberg KJ; Precision Immunotherapy Alliance, The University of Oslo, Oslo, Norway.; Department of Cancer Immunology, Institute for Cancer Research Oslo, Oslo University Hospital, Oslo, Norway.; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Montagut C; University Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology, Hospital del Mar, Barcelona, Spain.; Albanell J; University Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology, Hospital del Mar, Barcelona, Spain.; Güell M; University Pompeu Fabra (UPF), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, ICREA, Barcelona, Spain.; López-Botet M; University Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Muntasell A; Hospital del Mar Research Institute (IMIM), Barcelona, Spain. aura.muntasell@uab.cat.; Institut de Biotecnologia i Biomedicina, Cell Biology, Physiology and Immunology Deptartments, Universitat Autònoma de Barcelona, Bellaterra, Spain. aura.muntasell@uab.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. aura.muntasell@uab.cat.

Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE

van Vliet AA; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; van den Hout MGCN; Erasmus MC Center for Biomics and Department of Cell Biology, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.; Steenmans D; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Duru AD; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Georgoudaki AM; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; de Gruijl TD; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; van IJcken WFJ; Erasmus MC Center for Biomics and Department of Cell Biology, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.; Spanholtz J; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Raimo M; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE

Lamers-Kok N; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands.; Panella D; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands.; Georgoudaki AM; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands.; Liu H; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands.; Özkazanc D; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands.; Kučerová L; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands.; Duru AD; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands.; Spanholtz J; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands.; Raimo M; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB, Oss, The Netherlands. monica@glycostem.com.

Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

van Vliet AA; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.; Peters E; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Vodegel D; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Steenmans D; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Raimo M; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Gibbs S; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.; de Gruijl TD; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.; Duru AD; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Spanholtz J; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.; Georgoudaki AM; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, the Netherlands.

Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Sayitoglu EC; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, United States.; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, United States.; Georgoudaki AM; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, United States.; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, United States.; Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.; Chrobok M; Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.; Ozkazanc D; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Josey BJ; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, United States.; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, United States.; Arif M; Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.; Kusser K; Translational Research and Economic Development, Nova Southeastern University, Fort Lauderdale, FL, United States.; Hartman M; Translational Research and Economic Development, Nova Southeastern University, Fort Lauderdale, FL, United States.; Chinn TM; Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, United States.; Potens R; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, United States.; Pamukcu C; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Krueger R; Translational Research and Economic Development, Nova Southeastern University, Fort Lauderdale, FL, United States.; Zhang C; Faculty of Dentistry, Oral & Craniofacial Sciences, Centre for Host-Microbiome Interactions, King's College London, London, United Kingdom.; Mardinoglu A; Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.; Faculty of Dentistry, Oral & Craniofacial Sciences, Centre for Host-Microbiome Interactions, King's College London, London, United Kingdom.; Alici E; Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.; Temple HT; Department of Surgery, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, United States.; Sutlu T; Department of Molecular Biology and Genetics, Bogaziçi University, Istanbul, Turkey.; Duru AD; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, United States.; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, United States.; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Parlar A; Nanotechnology Research and Application Center, Sabanci University, Istanbul, Turkey.; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Sayitoglu EC; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, USA.; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.; Ozkazanc D; Nanotechnology Research and Application Center, Sabanci University, Istanbul, Turkey.; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Georgoudaki AM; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, USA.; Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.; Pamukcu C; Nanotechnology Research and Application Center, Sabanci University, Istanbul, Turkey.; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Aras M; Nanotechnology Research and Application Center, Sabanci University, Istanbul, Turkey.; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Josey BJ; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, USA.; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.; Chrobok M; Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.; Branecki S; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, USA.; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.; Zahedimaram P; Nanotechnology Research and Application Center, Sabanci University, Istanbul, Turkey.; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Ikromzoda L; Nanotechnology Research and Application Center, Sabanci University, Istanbul, Turkey.; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Alici E; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, USA.; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.; Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.; Erman B; Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.; Duru AD; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, USA.; Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Sutlu T; Nanotechnology Research and Application Center, Sabanci University, Istanbul, Turkey.

Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

Saha T; Division of Engineering in Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States.; van Vliet AA; Glycostem Therapeutics B.V., Oss, Netherlands.; Cui C; Xsphera Biosciences Inc., Boston, MA, United States.; Macias JJ; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, United States.; Kulkarni A; Division of Engineering in Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States.; Pham LN; Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States.; Lawler S; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, United States.; Spanholtz J; Glycostem Therapeutics B.V., Oss, Netherlands.; Georgoudaki AM; Glycostem Therapeutics B.V., Oss, Netherlands.; Duru AD; Glycostem Therapeutics B.V., Oss, Netherlands.; Goldman A; Division of Engineering in Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States.; Glycostem Therapeutics B.V., Oss, Netherlands.; Cancer Immunology, Dana Farber/Harvard Cancer Center, Boston, MA, United States.

Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653173 Publication Model: eCollection Cited Medium: Print ISSN: 2296-889X (Print) Linking ISSN: 2296889X NLM ISO Abbreviation: Front Mol Biosci Subsets: PubMed not MEDLINE

van Vliet AA; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, The Netherlands.; Georgoudaki AM; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, The Netherlands.; Raimo M; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, The Netherlands.; de Gruijl TD; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Spanholtz J; Glycostem Therapeutics, Kloosterstraat 9, 5349 AB Oss, The Netherlands.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Georgoudaki AM; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Khodabandeh S; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Puiac S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.; Persson CM; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Larsson MK; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Lind M; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Hammarfjord O; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Nabatti TH; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Wallin RP; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Yrlid U; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.; Rhen M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.; Kumar V; Department of Pathology, University of Chicago, Chicago, IL, USA.; Chambers BJ; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Publisher: Wiley Country of Publication: United States NLM ID: 8706300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1711 (Electronic) Linking ISSN: 08189641 NLM ISO Abbreviation: Immunol Cell Biol Subsets: MEDLINE

Tsagozis P; Department of Orthopedics, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Gonzalez-Molina J; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Georgoudaki AM; Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden.; NSU Cell Therapy Institute, Nova Southeastern University, Fort Lauderdale, FL, USA.; Lehti K; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Carlson J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.; Lundqvist A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Haglund F; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.; Ehnman M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. monika.ehnman@ki.se.; PO Bröst- och endokrina tumörer och sarkom, Tema Cancer, BioClinicum, Karolinska University Hospital, Stockholm, Sweden. monika.ehnman@ki.se.

Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 0121103 Publication Model: Print Cited Medium: Print ISSN: 0065-2598 (Print) Linking ISSN: 00652598 NLM ISO Abbreviation: Adv Exp Med Biol Subsets: MEDLINE

Hafstrand I; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, Solna, SE-17176 Stockholm, Sweden.; Sayitoglu EC; Nova Southeastern University Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33301.; Apavaloaei A; Department of Life Sciences and Chemistry, Jacobs University Bremen, 28759 Bremen, Germany.; Josey BJ; Nova Southeastern University Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33301.; Sun R; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, Solna, SE-17176 Stockholm, Sweden.; Han X; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, Solna, SE-17176 Stockholm, Sweden.; Pellegrino S; Department of Pharmaceutical Science, General and Organic Chemistry Section, University of Milano, 20133 Italy.; Ozkazanc D; Nova Southeastern University Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33301.; Potens R; Nova Southeastern University Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33301.; Janssen L; Department of Life Sciences and Chemistry, Jacobs University Bremen, 28759 Bremen, Germany.; Nilvebrant J; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, AlbaNova University Center, Royal Institute of Technology, SE-10691 Stockholm, Sweden.; Nygren PÅ; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, AlbaNova University Center, Royal Institute of Technology, SE-10691 Stockholm, Sweden.; Sandalova T; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, Solna, SE-17176 Stockholm, Sweden.; Springer S; Department of Life Sciences and Chemistry, Jacobs University Bremen, 28759 Bremen, Germany.; Georgoudaki AM; Nova Southeastern University Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33301.; Duru AD; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, Solna, SE-17176 Stockholm, Sweden.; Nova Southeastern University Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33301.; Achour A; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, Solna, SE-17176 Stockholm, Sweden; adnane.achour@ki.se.

Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Smith LE; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Olszewski MA; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Georgoudaki AM; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Wagner AK; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Hägglöf T; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Karlsson MC; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Dominguez-Villar M; Department of Biomedicine, Biotechnology and Public Health (Immunology), University of Cadiz and Puerto Real University Hospital Research Unit, School of Medicine, Cadiz, Spain; Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.; Garcia-Cozar F; Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.; Mueller S; Codagenix, Stony Brook, New York, USA; and.; Ravens I; Institute of Immunology, Hannover Medical School, Hannover, Germany.; Bernhardt G; Institute of Immunology, Hannover Medical School, Hannover, Germany.; Chambers BJ; Department of Medicine, Center for Infectious Medicine, F59, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; benedict.chambers@ki.se.

Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-3673 (Electronic) Linking ISSN: 07415400 NLM ISO Abbreviation: J Leukoc Biol Subsets: MEDLINE

Prokopec KE; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet Solna Campus, Karolinska Institutet, SE-171 77 Stockholm, Sweden; Program in Cellular and Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115;; Georgoudaki AM; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet Solna Campus, Karolinska Institutet, SE-171 77 Stockholm, Sweden;; Sohn S; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet Solna Campus, Karolinska Institutet, SE-171 77 Stockholm, Sweden;; Wermeling F; Rheumatology Unit, Department of Medicine, Karolinska Institutet Solna Campus, Karolinska Institutet, and Karolinska University Hospital, SE-171 76 Stockholm, Sweden; and.; Grönlund H; Department of Clinical Neuroscience, Karolinska Institutet, SE-171 76 Stockholm, Sweden.; Lindh E; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet Solna Campus, Karolinska Institutet, SE-171 77 Stockholm, Sweden;; Carroll MC; Program in Cellular and Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115;; Karlsson MC; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet Solna Campus, Karolinska Institutet, SE-171 77 Stockholm, Sweden; mikael.karlsson@ki.se.

Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE

Parsa R; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, S-171 76 Stockholm, Sweden.; Lund H; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, S-171 76 Stockholm, Sweden.; Georgoudaki AM; B Cell Biology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, S-171 77 Stockholm, Sweden.; Zhang XM; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, S-171 76 Stockholm, Sweden.; Ortlieb Guerreiro-Cacais A; Neuroimmunology, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, S-171 76 Stockholm, Sweden.; Grommisch D; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, S-171 76 Stockholm, Sweden.; Warnecke A; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, S-171 76 Stockholm, Sweden.; Croxford AL; Institute of Experimental Immunology, University of Zurich, CH-8057 Zürich, Switzerland.; Jagodic M; Neuroimmunology, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, S-171 76 Stockholm, Sweden.; Becher B; Institute of Experimental Immunology, University of Zurich, CH-8057 Zürich, Switzerland.; Karlsson MC; B Cell Biology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, S-171 77 Stockholm, Sweden.; Harris RA; Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, S-171 76 Stockholm, Sweden Robert.Harris@ki.se.

Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE

Georgoudaki AM; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17176 Stockholm, Sweden.; Prokopec KE; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17176 Stockholm, Sweden.; Boura VF; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17176 Stockholm, Sweden.; Hellqvist E; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17176 Stockholm, Sweden.; Sohn S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17176 Stockholm, Sweden.; Östling J; Department of Oncology and Pathology, Karolinska Institutet, 17176 Stockholm, Sweden.; Dahan R; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065, USA.; Harris RA; Department of Clinical Neuroscience, Karolinska Institutet and Centre for Molecular Medicine, Karolinska University Hospital, 17176 Stockholm, Sweden.; Rantalainen M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17176 Stockholm, Sweden.; Klevebring D; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17176 Stockholm, Sweden.; Sund M; Department of Surgical and Perioperative Sciences, Umeå University, 90187 Umeå, Sweden.; Brage SE; Department of Oncology and Pathology, Karolinska Institutet and Karolinska University Hospital, 17176 Stockholm, Sweden.; Fuxe J; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17176 Stockholm, Sweden.; Rolny C; Department of Oncology and Pathology, Karolinska Institutet, 17176 Stockholm, Sweden.; Li F; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065, USA; Shanghai Institute of Immunology and Hongqiao International Institute of Medicine, Faculty of Basic Medicine, School of Medicine, Shanghai Tongren Hospital, Shanghai Jiao Tong University, and Collaborative Innovation Center of Systems Biomedicine, Shanghai 200025, China.; Ravetch JV; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065, USA.; Karlsson MC; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17176 Stockholm, Sweden. Electronic address: mikael.karlsson@ki.se.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Pang MF; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.; Georgoudaki AM; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Lambut L; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Johansson J; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Tabor V; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Hagikura K; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Division of Cell Regeneration and Transplantation, Department of Functional Morphology, Nihon University School of Medicine, Tokyo, Japan.; Jin Y; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Jansson M; Department of Surgical and Perioperative Sciences/Surgery, Umea University, Umea, Sweden.; Alexander JS; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.; Nelson CM; Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.; Jakobsson L; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Betsholtz C; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Sund M; Department of Surgical and Perioperative Sciences/Surgery, Umea University, Umea, Sweden.; Karlsson MC; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Fuxe J; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

Gehrmann U; Department of Medicine Solna, Karolinska Institutet, Translational Immunology Unit, Stockholm, Sweden.; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Lindmark E; Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, SE-171 76 Stockholm, Sweden.; Chen Y; Georgoudaki AM; Dudziak D; Lindh E; Adams WC; Loré K; Winqvist O; Chambers BJ; Karlsson MC

Publisher: Academic Press Country of Publication: England NLM ID: 8812164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9157 (Electronic) Linking ISSN: 08968411 NLM ISO Abbreviation: J Autoimmun Subsets: MEDLINE